LIXTE BIOTECHNOLOGY HOLDINGS, INC. Common Stock Shares Outstanding

Quick Answer

LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported Common Stock Shares Outstanding of 8.79 million shares for the year ending 2025.

  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. showed an increase of +290.8% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2006 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 17 years of available data (2006 to 2025), LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s Common Stock Shares Outstanding has declined by 64.8%.
  • Historical annual values: Fiscal year 2025: 8.79 million shares | Fiscal year 2024: 2.25 million shares | Fiscal year 2023: 2.25 million shares | Fiscal year 2022: 1.66 million shares | Fiscal year 2021: 13.75 million shares | Fiscal year 2020: 12.40 million shares | Fiscal year 2019: 11.17 million shares | Fiscal year 2018: 67.05 million shares | Fiscal year 2017: 58.03 million shares | Fiscal year 2016: 47.88 million shares | Fiscal year 2015: 47.88 million shares | Fiscal year 2014: 45.48 million shares | Fiscal year 2013: 41.58 million shares | Fiscal year 2012: 41.58 million shares | Fiscal year 2011: 35.26 million shares | Fiscal year 2010: 35.08 million shares | Fiscal year 2006: 25.00 million shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: